First report of pulmonary large cell neuroendocrine carcinoma treated with stereotactic body radiation therapy

ConclusionsThis first report of SBRT for pulmonary LCNEC demonstrates that SBRT is a feasible modality for this rare disease. A multidisciplinary thoracic oncology approach involving medical oncology, thoracic surgery, radiation oncology and pulmonology is strongly recommended to ensure proper patient selection for receipt of SBRT.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research